Asaf Poran
BioNTech (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, vaccines and immunoinformatics approaches, Immunotherapy and Immune Responses, CAR-T cell therapy research, Influenza Virus Research Studies
Most-Cited Works
- → BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans(2021)818 cited
- → A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer(2020)716 cited
- → Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera(2022)383 cited
- → Single-cell RNA sequencing reveals a signature of sexual commitment in malaria parasites(2017)262 cited
- → DNA methylation disruption reshapes the hematopoietic differentiation landscape(2020)255 cited
- → Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction(2019)254 cited
- → Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer(2022)211 cited
- → BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans(2020)171 cited
- → T cell receptor repertoires of mice and humans are clustered in similarity networks around conserved public CDR3 sequences(2017)169 cited
- → Revisiting the initial steps of sexual development in the malaria parasite Plasmodium falciparum(2018)158 cited